– Permanent, product-specific J-code facilitates efficient claims and reimbursement –
– Conference Call Today at 4:30 p.m. ET
Barchart Research What to Expect from OMER Earnings OMER Generated March 30, 2026 Current Price $9.81 EPS Estimate $-0.55 Consensus Rating Moderate Buy Average Move 18.93% Omeros Burns Cash While Everyone...
Barchart Research What to Expect from OMER Earnings OMER Generated March 27, 2026 Current Price $9.88 EPS Estimate $-0.55 Consensus Rating Moderate Buy Average Move 18.93% Omeros Has Been Quietly Burning...
Omeros Corporation (NASDAQ: OMER) today announced that it will issue its financial results for the fourth quarter and year ended December 31, 2025, on Tuesday, March 31, 2026 after market close. Omeros...
Omeros Corporation (NASDAQ: OMER) today announced that it will host an industry session at the 52 nd Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) on...
— OncotoX-AML Effectively Ablated Myeloid Progenitor Cells that Give Rise to AML in Cancer Patients —
— Initial Orders Received and Fulfilled from Multiple Transplant Centers, with YARTEMLEA Now Administered to Both Adult and Pediatric Patients with TA-TMA —
— Omeros to Host Conference Call Wednesday, January 7, 2026 at 4:30 p.m. ET —